These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 508511

  • 21. [Hypotensive effect and changes of arterial pressure variability induced by treatment with labetalol in patients with slight and moderate arterial hypertension].
    Palatini P, Pessina AC, Sperti G, Ventura E, Agnoletto V, Semplicini A, Hlede M, Gava R, Mormino P, Dal Palù C.
    G Ital Cardiol; 1983; 13(1):18-22. PubMed ID: 6873535
    [Abstract] [Full Text] [Related]

  • 22. Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight.
    Kornerup HJ, Pedersen EB, Christensen NJ, Pedersen A, Pedersen G.
    Acta Med Scand Suppl; 1979; 625():59-64. PubMed ID: 34981
    [No Abstract] [Full Text] [Related]

  • 23. Rapid onset of action of oral labetalol in severe hypertension.
    Ghose RR, Sampson A.
    Curr Med Res Opin; 1977; 5(2):147-51. PubMed ID: 340130
    [Abstract] [Full Text] [Related]

  • 24. Treatment of moderate to severe hypertension with labetalol.
    Tötterman KJ, Eisalo A.
    Acta Med Scand Suppl; 1981; 646():115-22. PubMed ID: 6941659
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.
    McNeil JJ, Anderson AE, Louis WJ, Morgan DJ.
    Br J Clin Pharmacol; 1979; 8(Suppl 2):157S-161S. PubMed ID: 526397
    [Abstract] [Full Text] [Related]

  • 26. Intravenous labetalol in hypertensive patients given by fast and slow injection.
    Pearson RM, Havard CW.
    Br J Clin Pharmacol; 1978 May; 5(5):401-5. PubMed ID: 350248
    [Abstract] [Full Text] [Related]

  • 27. Treatment of severe hypertension with intravenous labetalol.
    Papademetriou V, Notargiacomo AV, Khatri IM, Freis ED.
    Clin Pharmacol Ther; 1982 Oct; 32(4):431-5. PubMed ID: 7116758
    [Abstract] [Full Text] [Related]

  • 28. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects].
    Cherchi A, Raffo M, Sau F, Seguro C, Pirisi R.
    Boll Soc Ital Cardiol; 1978 Oct; 23(1):158-76. PubMed ID: 754770
    [No Abstract] [Full Text] [Related]

  • 29. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO, Andersen GS, Jensen NB, Andersson E.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [Abstract] [Full Text] [Related]

  • 30. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B.
    Postgrad Med J; 1980 Aug; 56 Suppl 2():65-8. PubMed ID: 7433346
    [Abstract] [Full Text] [Related]

  • 31. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A, Allonen H, Kleimola T.
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):71-5. PubMed ID: 422304
    [Abstract] [Full Text] [Related]

  • 32. Intravenous labetalol in severe hypertension.
    Dal Palu C, Pessina AC, Semplicini A, Hlede M, Morandin F, Palatini P, Sperti G, Rossi GP.
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):97S-99S. PubMed ID: 7093106
    [Abstract] [Full Text] [Related]

  • 33. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
    Mehta J, Feldman RL, Marx JD, Kelly GA.
    Am J Med; 1983 Oct 17; 75(4A):32-9. PubMed ID: 6638039
    [Abstract] [Full Text] [Related]

  • 34. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982 Oct 17; 12(10):729-35. PubMed ID: 7182212
    [Abstract] [Full Text] [Related]

  • 35. The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.
    Agabiti-Rosei E, Alicandri CL, Beschi M, Castellano M, Fariello R, Montini E, Muiesan ML, Romanelli G, Muiesan G.
    Br J Clin Pharmacol; 1982 Jun 17; 13(1 Suppl):87S-92S. PubMed ID: 7093104
    [Abstract] [Full Text] [Related]

  • 36. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent.
    Stern N, Teicher A, Rosenthal T.
    Clin Cardiol; 1982 Feb 17; 5(2):125-30. PubMed ID: 7039899
    [Abstract] [Full Text] [Related]

  • 37. Labetalol in the difficult hypertensive patient in general practice.
    Harris C.
    Curr Med Res Opin; 1978 Feb 17; 5(8):618-24. PubMed ID: 710176
    [Abstract] [Full Text] [Related]

  • 38. Labetalol infusion for the treatment of hypertension in acute myocardial infarction.
    Timmis AD, Fowler MB, Jaggarao NS, Chamberlain DA.
    Eur Heart J; 1980 Dec 17; 1(6):413-6. PubMed ID: 7274255
    [No Abstract] [Full Text] [Related]

  • 39. Rate of onset of hypotensive effect of oral labetalol.
    Serlin MJ, Orme MC, Maciver M, Green GJ, Macnee CM, Breckenridge AM.
    Br J Clin Pharmacol; 1979 Feb 17; 7(2):165-8. PubMed ID: 760748
    [Abstract] [Full Text] [Related]

  • 40. Intravenous labetalol in the emergency treatment of hypertension.
    Vidt DG.
    J Clin Hypertens; 1985 Jun 17; 1(2):179-86. PubMed ID: 3915322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.